Ursodeoxycholic acid is associated with improved long-term outcome in patients with primary sclerosing cholangitis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ursodeoxycholic acid is associated with improved long-term outcome in patients with primary sclerosing cholangitis
Authors
Keywords
-
Journal
JOURNAL OF GASTROENTEROLOGY
Volume 57, Issue 11, Pages 902-912
Publisher
Springer Science and Business Media LLC
Online
2022-09-07
DOI
10.1007/s00535-022-01914-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association of bezafibrate with transplant-free survival in patients with primary biliary cholangitis
- (2021) Atsushi Tanaka et al. JOURNAL OF HEPATOLOGY
- A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis
- (2020) Kris V. Kowdley et al. JOURNAL OF HEPATOLOGY
- The nonsteroidal FXR agonist cilofexor (GS-9674) improves markers of cholestasis and liver injury in patients with PSC
- (2019) Michael Trauner et al. HEPATOLOGY
- Effects of Vedolizumab in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases
- (2019) Kate D. Lynch et al. Clinical Gastroenterology and Hepatology
- Vedolizumab Therapy is Ineffective for Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A GETAID Multicentre Cohort Study
- (2019) Benedicte Caron et al. Journal of Crohns & Colitis
- British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis
- (2019) Michael Huw Chapman et al. GUT
- Design and Endpoints for Clinical Trials in Primary Sclerosing Cholangitis
- (2018) Cyriel Y. Ponsioen et al. HEPATOLOGY
- Clinical guidelines for primary sclerosing cholangitis 2017
- (2018) Hiroyuki Isayama et al. JOURNAL OF GASTROENTEROLOGY
- A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis
- (2018) Christophe Corpechot et al. NEW ENGLAND JOURNAL OF MEDICINE
- Simtuzumab for Primary Sclerosing Cholangitis: Phase 2 Study Results With Insights on the Natural History of the Disease
- (2018) Andrew J. Muir et al. HEPATOLOGY
- Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring System
- (2018) E C Goode et al. HEPATOLOGY
- Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial
- (2018) Gideon M. Hirschfield et al. JOURNAL OF HEPATOLOGY
- No negative impact of serum IgG4 levels on clinical outcome in 435 patients with primary sclerosing cholangitis from Japan
- (2017) Atsushi Tanaka et al. Journal of Hepato-Biliary-Pancreatic Sciences
- nor Ursodeoxycholic acid improves cholestasis in primary sclerosing cholangitis
- (2017) Peter Fickert et al. JOURNAL OF HEPATOLOGY
- Primary sclerosing cholangitis – a comprehensive review
- (2017) Tom H. Karlsen et al. JOURNAL OF HEPATOLOGY
- ACG Clinical Guideline: Primary Sclerosing Cholangitis
- (2015) Keith D Lindor et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Prospective study of bezafibrate for the treatment of primary sclerosing cholangitis
- (2015) Suguru Mizuno et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Reduction in alkaline phosphatase is associated with longer survival in primary sclerosing cholangitis, independent of dominant stenosis
- (2014) C. Rupp et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Association Between Reduced Levels of Alkaline Phosphatase and Survival Times of Patients With Primary Sclerosing Cholangitis
- (2013) Lina Lindström et al. Clinical Gastroenterology and Hepatology
- Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan
- (2013) Atsushi Tanaka et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Anticholestatic effects of bezafibrate in patients with primary biliary cirrhosis treated with ursodeoxycholic acid
- (2012) Akira Honda et al. HEPATOLOGY
- Improvement of serum alkaline phosphatase to
- (2012) Said Al Mamari et al. JOURNAL OF HEPATOLOGY
- Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis
- (2011) C. K. Triantos et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis
- (2011) Peter P. Stanich et al. DIGESTIVE AND LIVER DISEASE
- Diagnosis and management of primary sclerosing cholangitis
- (2009) Roger Chapman et al. HEPATOLOGY
- High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis
- (2009) Keith D. Lindor et al. HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of cholestatic liver diseases
- (2009) JOURNAL OF HEPATOLOGY
- The challenges in primary sclerosing cholangitis – Aetiopathogenesis, autoimmunity, management and malignancy
- (2008) Tobias J. Weismüller et al. JOURNAL OF HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now